Features - Tropical diseases

Filter

Current filters:

Tropical diseases

Popular Filters

51 to 75 of 83 results

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Sanofi and PATH launch large-scale production of semi-synthetic artemisinin in Italy

12-04-2013

French drug major Sanofi (Euronext: SAN) and non-profit global health organization PATH's Drug Development…

artemisininPharmaceuticalProductionSanofiTropical diseases

News briefs: Novartis drops Ruvise MAA; B-MS settlement; Germany donates to Global Fund

25-01-2013

The European Medicines Agency says it has been formally notified by Swiss drug major Novartis (NOVN:…

Anti-viralsBMS-986094Bristol-Myers SquibbFinancialLegalNovartisPharmaceuticalRare diseasesRegulationRuviseTropical diseases

New executive director of the Global Fund outlines ambitious agenda

21-01-2013

Mark Dybul yesterday took charge as executive director of the Global Fund to Fight AIDS, Tuberculosis…

Anti-viralsAntibiotics and Infectious diseasesFinancialManagementPharmaceuticalTropical diseases

New report shows major increase in pharmaceutical R&D for neglected diseases

16-01-2013

R&D, health system capacity-strengthening efforts, and medicine donations comprise the pharmaceutical…

GlobalPharmaceuticalRare diseasesResearchTropical diseases

PATH MVI links with Inovio on malaria vaccines and delivery technology

07-01-2013

The USA-based PATH Malaria Vaccine Initiative (MVI) has announced a follow-on collaboration with drugmaker…

Inovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

New report signals slowdown in the fight against malaria

17-12-2012

During the past decade, a concerted effort by endemic countries, donors and global malaria partners led…

FinancialHealthcarePharmaceuticalTropical diseases

Time for government action on investing in neglected diseases R&D

03-12-2012

A five-year review of global neglected disease R&D funding shows that, despite increased investment of…

FinancialPharmaceuticalRare diseasesResearchTropical diseases

Astellas collaborates with AIST for neglected tropical diseases

23-10-2012

Japanese drug major Astellas Pharma (TYO: 4503) has signed a collaborative drug discovery research agreement…

Asia-PacificAstellas PharmaPharmaceuticalResearchTropical diseases

Astellas links with KEK on tropical diseases; Upgraded by CS analysts

25-09-2012

Japanese drug major Astellas Pharma (TYO: 4503) has entered into a collaboration with the High Energy…

Astellas PharmaFinancialGenito-urinaryMyrbetriqOncologyPharmaceuticalResearchTropical diseasesXtandi

Eisai's Fycompa gets first EU launch, in UK; links with Sabine Vaccine Inst

13-09-2012

Japanese drug major Eisai (TYO: 4523) has announced the first European launch today of Fycompa (perampanel),…

EisaiFycompaMarkets & MarketingNeurologicalPharmaceuticalResearchTropical diseasesVaccines

Astellas and Tokyo-Tech collaborate on neglected disease research

31-07-2012

The Tokyo Institute of Technology (Tokyo-Tech) and Japanese drug major Astellas Pharma (TYO: 4503) have…

Astellas PharmaPharmaceuticalRare diseasesResearchTropical diseases

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations

25-07-2012

French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Novavax and Cadila in public/private malaria vaccine collaboration

17-07-2012

USA-based clinical-stage firm Novavax (Nasdaq: NVAX), CPL Biologicals (CPLB) - a joint-venture biotechnology…

Cadila PharmaceuticalsCPL BiologicalsNovavaxPharmaceuticalResearchTropical diseasesVaccines

New public-private partnership to develop a treatment for schistosomiasis-infected pre-school children

02-07-2012

A newly established international public-private partnership (PPP) between the Dutch non-profit organization…

Astellas PharmaMerck KGaAMerck SeronoPharmaceuticalpraziquantelResearchTropical diseases

Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi

14-06-2012

As a first critical step of its new strategy to enter into the field of neglected tropical diseases (NTD)…

Astellas PharmaPharmaceuticalResearchTropical diseases

Scientists say new process would make anti-malarial drug less costly

24-05-2012

Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease…

artemisininGenericsPricingResearchTropical diseases

Ranbaxy debuts first Indian-developed malaria drug, Synriam

27-04-2012

Indian drug major Ranbaxy (AB: B) said yesterday - coinciding with World Malaria Day - that it is "opening…

Asia-PacificDaiichi SankyoMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSynriamTropical diseases

Dundee, GSK and Wellcome Trust collaborate for neglected diseases

06-03-2012

The University of Dundee, UK, has received over ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������£10…

FinancialGlaxoSmithKlinePharmaceuticalResearchTropical diseases

Research-based pharma pledges on neglected tropical diseases

31-01-2012

The research-based pharmaceutical industry has announced donations of 14 billion treatments this decade…

FinancialGlobalPharmaceuticalResearchTropical diseases

Fake drugs dashing hopes of controlling malaria in Africa

17-01-2012

The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldTropical diseases

51 to 75 of 83 results

Back to top